ANGITIA BIOPHARMACEUTICALS
Angitia Biopharmaceuticals is a global biotechnology company focusing on the discovery and development of innovative therapeutics for serious musculoskeletal diseases.
ANGITIA BIOPHARMACEUTICALS
Social Links:
Industry:
Biopharma Biotechnology Health Care Medical
Founded:
2018-01-01
Address:
Guangzhou, Guangdong, China
Country:
China
Website Url:
http://www.angitiabio.com
Total Employee:
101+
Status:
Active
Contact:
206-232-9813
Email Addresses:
[email protected]
Total Funding:
156 M USD
Technology used in webpage:
Euro CrUX Top 50m CrUX Dataset
Similar Organizations
Ansun BioPharma
Ansun BioPharma is a clinical-stage biopharmaceutical company focused on the development of host-directed anti-viral.
Biotheus
Biotheus is a biotech company that focuses on the discovery and development of antibody-based therapeutics.
Blue Water Vaccines
Blue Water Vaccines is a company developing a universal flu vaccine based on technology.
Heyuan Biotechnology
A leading high-tech enterprise of biomedical basic research, gene therapy drug incubation, and clinical-level gene therapy
MabSpace Biosciences
MabSpace Biosciences is a biotech company focused on discovery & development of innovative antibody based therapeutics for cancer.
Pilot Biotechnology
Pilot Biotechnology is an industrial biotechnology company engaged in the development, production, and sales of health care products.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Relation Therapeutics
Relation Therapeutics engages in humanizing drug discovery and development.
Investors List
Yuekai Securities
Yuekai Securities investment in Series B - Angitia Biopharmaceuticals
Yonghua Capital
Yonghua Capital investment in Series B - Angitia Biopharmaceuticals
Lichen Capital
Lichen Capital investment in Series B - Angitia Biopharmaceuticals
OrbiMed
OrbiMed investment in Series B - Angitia Biopharmaceuticals
Morningside Group
Morningside Group investment in Series B - Angitia Biopharmaceuticals
3H Health Investment
3H Health Investment investment in Series B - Angitia Biopharmaceuticals
Legend Capital
Legend Capital investment in Series B - Angitia Biopharmaceuticals
Oriza Holdings
Oriza Holdings investment in Series B - Angitia Biopharmaceuticals
Morningside Venture Investments
Morningside Venture Investments investment in Series B - Angitia Biopharmaceuticals
guangzhou junshi
guangzhou junshi investment in Series A - Angitia Biopharmaceuticals
Official Site Inspections
http://www.angitiabio.com Semrush global rank: 11.45 M Semrush visits lastest month: 162
- Host name: 47.90.152.47
- IP address: 47.90.152.47
- Location: San Mateo United States
- Latitude: 37.5517
- Longitude: -122.33
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94402
More informations about "Angitia Biopharmaceuticals"
Angitia Biopharmaceuticals - Crunchbase Company Profile
Angitia Biopharmaceuticals is a global biotechnology company focusing on the discovery and development of innovative therapeutics.See details»
ANGITIA - INNOVATION FOR PATIENTS - angitiabio.com
Luna has accumulated over 15 years of experience in the healthcare industry across multinational companies (MNCs), venture capital firms, and startup companies, focusing on business โฆSee details»
Angitia Biopharmaceuticals - PitchBook
Information on valuation, funding, cap tables, investors, and executives for Angitia Biopharmaceuticals. Use the PitchBook Platform to explore the full profile.See details»
Angitia Biopharmaceuticals | LinkedIn
Angitia is a clinical-stage biotechnology company focused on discovering and developing breakthrough therapeutics that address the key unmet medical needs of serious musculoskeletal diseases. With ...See details»
Angitia - Products, Competitors, Financials, Employees, โฆ
Angitia operates as a clinical-stage biotechnology company. It focuses on the discovery and development of therapeutics for serious musculoskeletal diseases. It develops products for โฆSee details»
Angitia Biopharmaceuticals Overview - SignalHire
Angitia is a clinical-stage biotechnology company focused on discovering and developing breakthrough therapeutics that address the key unmet medical needs of serious โฆSee details»
Angitia Biopharmaceuticals Guangzhou Ltd. - Patsnap
Angitia Biopharmaceuticals Guangzhou Ltd. is a biopharmaceutical company based in Guangzhou, China, specializing in the development of treatments for musculoskeletal โฆSee details»
Angitia Biopharmaceuticals - ZoomInfo
View Angitia Biopharmaceuticals (www.angitiabio.com) location in Guangdong, China , revenue, industry and description. Find related and similar companies as well as employees by title and โฆSee details»
ANGITIA - INNOVATION FOR PATIENTS - angitiabio.com
Oct 17, 2023 With the teamโs experience and scientific expertise in novel drug development, Angitia is dedicated to bringing innovative therapies to help patients in need. Learn more at โฆSee details»
Angitia Biopharmaceuticals - ้ข่ฑ (ไธญๅฝ)
Angitia Biopharmaceuticals | ๅจ้ข่ฑไธๆ 1,561 ไฝๅ ณๆณจ่ ใDeveloping innovative medicines to address serious musculoskeletal diseases | Angitia is a clinical-stage biotechnology company โฆSee details»
Angitia Biopharmaceuticals - Drug pipelines, Patents, Clinical trials ...
Explore Angitia Biopharmaceuticals with its drug pipeline, therapeutic area, technology platform, .See details»
Angitia Biopharmaceuticals - VentureRadar
Canton Biologics specializes in the large molecule biopharmaceutical CDMO sector, offering end-to-end services from biopharmaceutical CMC development to commercial production and โฆSee details»
ANGITIA - INNOVATION FOR PATIENTS - angitiabio.com
Terms of Use Privacy Policy Cookies Policy Copyright © 2024 Angitia Biopharmaceuticals. All Rights Reserved ็ฒคICPๅค19077882ๅทANGITIA - INNOVATION FOR PATIENTSSee details»
Angitia Biopharmaceuticals Presents First-in-Human Data on
Sep 30, 2024 Learn more at www.angitiabio.com. Investor & Media Contact: Forward-Looking Statements This press release is prepared by Angitia (the โCompanyโ, โWeโ) for informational โฆSee details»
Series B - Angitia Biopharmaceuticals - Crunchbase
Oct 19, 2023 Recent News News โข Oct 27, 2023 BioWorld Financial Watch โ Angitia advancing musculoskeletal pipeline with $46M series B News โข Oct 19, 2023 ChinaVenture โ ๅฎๆต็็ โฆSee details»
Angitia Biopharmaceuticals Presents First-in-Human Data on โฆ
Sep 30, 2024 Clinical data demonstrated treatment with AGA2118 resulted in dose-dependent increases in bone mineral densityWOODLAND HILLS, Calif., Sept. 30, 2024 (GLOBE โฆSee details»
ANGITIA - INNOVATION FOR PATIENTS - angitiabio.com
Apr 8, 2024 Leveraging the team's extensive experience and scientific acumen in novel drug development, Angitia is committed to providing groundbreaking therapies to satisfy key unmet โฆSee details»
Angitia Biopharmaceuticals Announces Dosing of First
Nov 4, 2024 Learn more at www.angitiabio.com. Investor & Media Contact: Forward-Looking Statements This press release is prepared by Angitia (the โCompanyโ, โWeโ) for informational โฆSee details»
ANGITIA - INNOVATION FOR PATIENTS - angitiabio.com
WOODLAND HILLS, California, USA, May 16, 2024 โ Angitia Biopharmaceuticals, a global, clinical-stage biotechnology company focused on the discovery and development of innovative โฆSee details»